NDC Package 60505-6289-0 Eribulin Mesylate

Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

60505-6289-0

Package Description:

1 VIAL, SINGLE-DOSE in 1 CARTON / 2 mL in 1 VIAL, SINGLE-DOSE

Product Code:

60505-6289

Proprietary Name:

Eribulin Mesylate

Non-Proprietary Name:

Eribulin Mesylate

Substance Name:

Eribulin Mesylate

Usage Information:

Eribulin is used to treat certain types of cancer (breast, liposarcoma). It works by slowing or stopping the growth of cancer cells.

11-Digit NDC Billing Format:

60505628900

Billing Unit:

ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

NDC to RxNorm Crosswalk:

RxCUI: 1045456 - eriBULin mesylate 1 MG in 2 ML Injection

RxCUI: 1045456 - 2 ML eribulin mesylate 0.5 MG/ML Injection

RxCUI: 1045456 - eribulin mesylate 1 MG per 2 ML Injection

Product Type:

Human Prescription Drug

Labeler Name:

Apotex Corp.

Dosage Form:

Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.

Administration Route(s):

Intravenous - Administration within or into a vein or veins.

Active Ingredient(s):

ERIBULIN MESYLATE .5 mg/mL

Pharmacologic Class(es):

Microtubule Inhibition - [PE] (Physiologic Effect)

Microtubule Inhibitor - [EPC] (Established Pharmacologic Class)

Sample Package:

FDA Application Number:

ANDA218047

Marketing Category:

ANDA - A product marketed under an approved Abbreviated New Drug Application.

Start Marketing Date:

05-06-2024

Listing Expiration Date:

12-31-2025

Exclude Flag:

Code Structure:

60505 - Apotex Corp.
- 60505-6289 - Eribulin Mesylate
  - 60505-6289-0 - 1 VIAL, SINGLE-DOSE in 1 CARTON / 2 mL in 1 VIAL, SINGLE-DOSE

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 60505-6289-0?

The NDC Packaged Code 60505-6289-0 is assigned to a package of 1 vial, single-dose in 1 carton / 2 ml in 1 vial, single-dose of Eribulin Mesylate, a human prescription drug labeled by Apotex Corp.. The product's dosage form is injection and is administered via intravenous form.

Is NDC 60505-6289 included in the NDC Directory?

Yes, Eribulin Mesylate with product code 60505-6289 is active and included in the NDC Directory. The product was first marketed by Apotex Corp. on May 06, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 60505-6289-0?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 60505-6289-0?

The 11-digit format is 60505628900. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-4-1	60505-6289-0	5-4-2	60505-6289-00

Table of Contents